Skip to main content

Table 1 Patient characteristics and biological agent treatment

From: Switching to an alternative biological agent in juvenile idiopathic arthritis (I)

Current treatment Sex M/F ANA (+) HLA B27 (+) RF (+) Uveitis Data of s-JIA Previous treatments
ETA n=58 11/47 19 (33%) 13 (22%) 2 (3%) 11 (19%)   ADA n=1
ADA n=16 2/14 6 (38%) 3 (19%)   14 (88%) 1 (7%) ETA n=8
IFX n=1
AK n=9 5/4   1 (11%)    9 (100%) ETA n=2
TCZ n=11 3/8   1 (9%)    6 (55%) ETA n=7
IFX n=2
AK n=6
ADA n=3
IFX n=2 1/1   2 (100%)     ETA n=2
Untreated* n=13 4/9 2 (15%) 2 (15%)   1 (8%) 1** (8%) ETA n=12
AK,TCZ n=1
  1. * In 12 cases ETA was withdrawn due to inactive disease. **One child had episodes of macrophage activation syndrome, being with and without biological agent.